By Sarah Terry-Cobo Courtesy of The Journal Record OKLAHOMA CITY – Like many people, Karl Nelson is working to keep his business costs under control. The vice president of operations at a small startup, VADovations, Nelson works to make sure the team of scientists stays on track when it comes to research and development. The [...] Post originally appeared at i2E – Innovation to Enterprise » Blog by Jim Stafford.
EpimedX is one of i2E’s most exciting and promising client companies. It is developing a treatment for Sickle Cell Disease that can actually reverse the condition by restoring what is known as fetal hemoglobin in patients. Oklahoma Magazine recently featured the company and co-founder Dr. Robert Broyles in its April editions. Here is the lead [...] Post originally appeared at i2E – Innovation to Enterprise » Blog by Jim Stafford.
By Greg Elwell Copyright © 2013, The Oklahoma Publishing Company An anti-brain tumor drug developed at the Oklahoma Medical Research Foundation could prove more effective than current therapies because it attacks cancer cells at multiple key points. A compound developed by OMRF scientist Dr. Rheal Towner has shown success in fighting extremely aggressive brain tumors [...] Post originally appeared at i2E – Innovation to Enterprise » Blog by Jim Stafford.
Editor’s note: This is the final installment of three articles by Kenneth Knoll on due diligence. Click here to read the first and second articles on the subject. Optimism is the mantra of entrepreneurship. Founders often spend a lot more time thinking about what can go right than what can go wrong. However, an interesting [...] Post originally appeared at i2E – Innovation to Enterprise » Blog by Kenneth Knoll.